iPierian raises additional Series B financing - MarketLine Financial Deals

iPierian raises additional Series B financing

iPierian raises additional Series B financing - MarketLine Financial Deals
iPierian raises additional Series B financing
Published Sep 08, 2010
3 pages — Published Sep 08, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

iPierian, Inc., a US-based biopharmaceutical company that applies cellular reprogramming and differentiation to find new molecular targets and develop proprietary therapeutics, has secured an additional round of Series B financing.

  
Source:
Document ID
MA33179_100927
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "iPierian raises additional Series B financing" Sep 08, 2010. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/iPierian-raises-additional-Series-B-financing-2052-44057>
  
APA:
MarketLine Financial Deals. (2010). iPierian raises additional Series B financing Sep 08, 2010. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/iPierian-raises-additional-Series-B-financing-2052-44057>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.